Ligand validation:9YHL

APR: ADENOSINE-5-DIPHOSPHORIBOSE

APR is a Ligand Of Interest in 9YHL designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9YHL_APR_B_201	100%	4%	0.043	0.986	4.31	1.33	14	5	0	0	100%	0.56
9YHL_APR_A_201	100%	4%	0.043	0.984	4.39	1.53	14	6	0	0	100%	0.64
9YHL_APR_C_201	99%	4%	0.049	0.98	4.39	1.47	13	4	0	0	100%	0.62
9YHL_APR_D_201	96%	4%	0.064	0.971	4.14	1.56	14	5	0	0	100%	0.88
9YHH_APR_A_201	99%	5%	0.047	0.986	4.04	1.48	13	5	0	0	100%	0.82
3GPO_APR_D_161	95%	43%	0.071	0.976	1.02	1.2	3	4	1	0	100%	1
9YHD_APR_D_201	74%	4%	0.089	0.917	4.46	1.44	15	6	1	0	100%	0.99
8YN0_APR_A_701	100%	40%	0.032	0.995	0.72	1.6	-	6	1	0	97%	0.95
2FAV_APR_B_477	100%	36%	0.038	0.985	0.92	1.58	2	5	0	1	100%	0.97
9QYF_APR_A_501	100%	39%	0.041	0.985	0.76	1.6	1	1	0	0	100%	0.5
7R3D_APR_BBB_401	98%	66%	0.062	0.983	0.63	0.69	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.